Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ
· Real-Time Price · USD
1.61
-0.03 (-1.83%)
At close: Sep 24, 2025, 3:59 PM
1.61
0.00%
After-hours: Sep 24, 2025, 04:10 PM EDT
-1.83% (1D)
Bid | 1.55 |
Market Cap | 7.37M |
Revenue (ttm) | 893.99K |
Net Income (ttm) | -21.65M |
EPS (ttm) | -22.36 |
PE Ratio (ttm) | -0.07 |
Forward PE | -0.87 |
Analyst | Hold |
Dividends | n/a |
Ask | 1.65 |
Volume | 36,867 |
Avg. Volume (20D) | 151,482 |
Open | 1.64 |
Previous Close | 1.64 |
Day's Range | 1.57 - 1.66 |
52-Week Range | 0.18 - 8.20 |
Beta | 0.26 |
Ex-Dividend Date | n/a |
About MYNZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MYNZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MYNZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+17.01%
Mainz Biomed shares are trading higher after the c...
Unlock content with
Pro Subscription
4 months ago
+4.82%
Mainz Biomed shares are trading higher after the company announced its Q1 corporate update and path to FDA premarket approval.